Navigation Links
Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
Date:8/19/2007

CHICAGO, Aug. 16 /PRNewswire-FirstCall/ -- Advanced Life Sciences Holdings, Inc. (Nasdaq: ADLS), today announced that on August 13, 2007 the Nasdaq Listings Qualifications Department informed the Company that the market value of its listed securities was below $50 million for 10 consecutive days, which is the requirement for continued listing on the Nasdaq Global Market according to Marketplace Rule 4450(b)(1)(A). Nasdaq also informed the Company that it is not in compliance with Marketplace Rule 4450(b)(1)(B), which requires total assets and total revenue of $50 million each for the most recently completed fiscal year or two of the last three most recently completed fiscal years.

(Logo: http://www.newscom.com/cgi-bin/prnh/20050428/CGTH039LOGO )

Advanced Life Sciences has been provided 30 calendar days, or until September 12, 2007, to regain compliance with the continued listing requirements of the Nasdaq Global Market. If at anytime prior to September 12, 2007, the market value of listed securities of the Company's common stock is $50 million or more for a minimum of 10 consecutive business days, this could constitute meeting the criteria for continued listing on the Nasdaq Global Market. Alternatively, the Company may apply to transfer its securities to the Nasdaq Capital Market, for which the Company believes it currently satisfies the financial and other listing requirements.

"We are confident in the progress we have made as a Company and are motivated to meet the compliance standards of the Nasdaq Global Market," stated Michael T. Flavin, Ph.D., chairman and chief executive officer of Advanced Life Sciences. "We
'/>"/>

SOURCE Advanced Life Sciences Holdings, Inc.

Copyright©2007 PR Newswire.

Page: 1 2 3 4

Related biology technology :

1. Achieving Reliable Protein Quantitation Results Using ICAT Reagents, MALDITOF Mass Spectrometry, and Advanced Data Interpretation Tool
2. Precision Testing for the Sciclone Advanced Liquid Handler Z8 Option
3. 384 Well Pipetting Precision and Accuracy Testing Using the Sciclone Advanced Liquid Handler
4. WARF expands license agreement with Advanced Cell Technology
5. Rockwells $1M gift to UWM will support advanced automation research
6. Advanced CIO: Technology execs must trumpet their success
7. FDA approves advanced digital mammography system
8. Tech Digest: Inacom; St. Michaels, St. Clares hospitals; Merge eMed; Advanced Data-Comm; Blue Cross and Blue Shield
9. Wisconsins insurance companies use advanced IT to speed relief
10. $60 Million Available in Advanced Tech Competition
11. Advanced Life Sciences to Hit the Road For $30 Million in Funding

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)...Nov. 19 Dr. Mate Hidvegi, inventor...to a press release issued on November 17 by Biroph...aking false and self-serving statements about its ...idvegi stated from his office in Budapest, Hungary...emar does not apply to AveULTRA, www.aveultra.co...
(Date:11/19/2009)...9 NeoStem, Inc. (NYSE Am...ollowing letter to its shareholders, discussing th...hina Biopharmaceuticals Holdings, Inc. (CHBP), an ... People,s Republic of China. The merger gives NeoS...maceutical Co. Ltd., CHBP,s primary operating subs...
(Date:11/19/2009)... and WALTHAM, Mass., Nov. 19 Arlin...s find that the leading driver of antibiotic selec...ectrum activity against gram-positive and gram-neg...hat can cause nosocomial pneumonia, surveyed Europ... agents that provide appropriate coverage against ...
(Date:11/19/2009)...9 /PRNewswire/ - Aegera Therapeutics Inc. announce...mized Phase 2B study of AEG35156, a targeted antis...iple oncology indications. ,, The study, entitl...X-Linked Inhibitor of Apoptosis (XIAP) Antisense A...bine and Idarubicin in AML Following Failure of a ...
Breaking Biology Technology:American BioSciences Rebuts Misleading Statements Made by Hungarian Competitor 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 3Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 2Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 3Aegera Therapeutics Initiates a Randomized Phase 2B Study with AEG35156 for the Treatment of Acute Myeloid Leukemia (AML) 2
... May 11 Pharmasset, Inc. (Nasdaq: VRUS ), a cli...scovering, developing, and commercializing novel d... results and operational highlights for the fiscal...sults , , Revenues were $1.9 million during the ...ion for the quarter ended March 31, 2008 and refle...
...1, 2009 Arena Pharmaceuticals, Inc. (Nasdaq: AR...t quarter ended March 31, 2009. , , Arena report...the first quarter of 2009 of $50.6 million, or $0....common stockholders in the first quarter of 2008 o...ing the positive lorcaserin BLOOM results was a si...
... joins the Digital Arts Alliance , , BATON ROUGE,...ed plans to support, for the second year in a row,...nsive Orientation for Students (BIOS) program with... class of Pearson Foundation Digital Arts Fellows ...es and pass them along to future program participa...
Other Biology Technology:Pharmasset Reports Fiscal Second Quarter 2009 Financial Results 2Pharmasset Reports Fiscal Second Quarter 2009 Financial Results 3Pharmasset Reports Fiscal Second Quarter 2009 Financial Results 4Pharmasset Reports Fiscal Second Quarter 2009 Financial Results 5Pharmasset Reports Fiscal Second Quarter 2009 Financial Results 6Pharmasset Reports Fiscal Second Quarter 2009 Financial Results 7Pharmasset Reports Fiscal Second Quarter 2009 Financial Results 8Arena Pharmaceuticals Announces First Quarter 2009 Financial Results 2Arena Pharmaceuticals Announces First Quarter 2009 Financial Results 3Arena Pharmaceuticals Announces First Quarter 2009 Financial Results 4Arena Pharmaceuticals Announces First Quarter 2009 Financial Results 5Arena Pharmaceuticals Announces First Quarter 2009 Financial Results 6Arena Pharmaceuticals Announces First Quarter 2009 Financial Results 7Arena Pharmaceuticals Announces First Quarter 2009 Financial Results 8Pearson Foundation Supports Incoming LSU Biology Students With 21st Century Learning Tools 2Pearson Foundation Supports Incoming LSU Biology Students With 21st Century Learning Tools 3
(Date:11/20/2009)... Using highly precise measurements of plasma lipop...ic resonance spectroscopy (NMR), researchers led b...nd Harvard Medical School in Boston, MA, the Frami... consortium in Stockholm, Sweden and Oxford, Engla...he whole genome among 17,296 women of European anc...
(Date:11/20/2009)... Researchers are invited to contribute their abstr...OF WCO ECCEO10), the largest global meeting devot...is research and patient care. The Congress will be...eginning today, abstracts can be submitted online ...sion deadline is February 4, 2010. , IOF and ESC...
(Date:11/20/2009)..., A key question in the origin of biological mol...ether billions of years ago from simple precursors...searchers in Italy have reconstructed one of the e...ains of RNA from individual subunits using nothing...t RNA was one of the first biological molecules pr...
Breaking Biology News(10 mins):Genetic analysis helps dissect molecular basis of cardiovascular disease 2Special sessions announced for World Congress on Osteoporosis 2010 - IOF WCO - ECCEO10 2Special sessions announced for World Congress on Osteoporosis 2010 - IOF WCO - ECCEO10 3National Coalition of Front Line Skilled Nursing Clinicians 3A Bipartisan Momentum to Stop CMS Medicare Regulation Subsequent Funding Cuts Grows in 53116 1National Coalition of Front Line Skilled Nursing Clinicians 3A Bipartisan Momentum to Stop CMS Medicare Regulation Subsequent Funding Cuts Grows in 53116 2National Coalition of Front Line Skilled Nursing Clinicians 3A Bipartisan Momentum to Stop CMS Medicare Regulation Subsequent Funding Cuts Grows in 53116 3National Coalition of Front Line Skilled Nursing Clinicians 3A Bipartisan Momentum to Stop CMS Medicare Regulation Subsequent Funding Cuts Grows in 53116 4Ricardo Launches Consortium to Evaluate Lubricant Challenges of Future Low Carbon Engine Technologies 13255 1Ricardo Launches Consortium to Evaluate Lubricant Challenges of Future Low Carbon Engine Technologies 13255 2Ricardo Launches Consortium to Evaluate Lubricant Challenges of Future Low Carbon Engine Technologies 13255 3Stryker Announces Election of New Director 53107 1Stryker Announces Election of New Director 53107 2
...uebec City, Canada - An international team of scie...iversity of Hull, Cardiff University) and Spain (D...pair of closely related species of East African ci...rising hundreds of species has puzzled evolutionar... gene adaptations which might explain why they do ...
...AINESVILLE, Fla. When the first four-legged animal...genetic recipe and simply extended the cooking tim... Wednesdays issue of the journal PLoS ONE. , Ev... billion years have the recipe for fingers in thei...hem. , While studying the mechanisms of developm...
...OSTONColon cancer patients who eat a diet high in ...erts a so-called Western diet may be increasing ...eport researchers at Dana-Farber Cancer Institute....he Journal of the American Medical Association, in...that has been treated with both surgery and chemot...
Other Biology News:Adaptation to parasites drive African fishes along different evolutionary paths 2Conquest of land began in shark genome 2Conquest of land began in shark genome 3'Western' diet linked to increased risk of colon cancer recurrence 2
Mouse Anti-zona radiata Monoclonal Antibody, Unconjugated, Clone MN-8C4 from Abcam
Goat Anti-PPP2R5D Polyclonal Antibody, Unconjugated from GeneTex
Rabbit Anti-TNR-R2 Polyclonal Antibody, Unconjugated from Spring Bioscience
Rabbit Anti-IL-23 P19 Polyclonal Antibody, Unconjugated from Abcam
Biology Products: